Open Access
Review
Table 2
Practical comparison of albendazole and mebendazole for the treatment of alveolar echinococcosis.
| Drug | Albendazole | Mebendazole |
|---|---|---|
| Prodrug | Yes | No |
| Pharmaceutical forms | 400 mg tablet | 500 mg tablet |
| 40 mg/mL oral suspension | 20 mg/mL oral suspension | |
| Initial dosage | 10–15 mg/kg/day | 40–50 mg/kg/day |
| Plasma concentration targets [13] | Peak of albendazole sulfoxide (4 h after administration): 0.65–3 μMol/L | Peak of mebendazole (4 h after administration): >250 nMol/L |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.